<DOC>
	<DOCNO>NCT02335073</DOCNO>
	<brief_summary>Liver biopsy reference method measurement liver fibrosis . But many limitation , sample error individual variation interpret result . Currently , serum liver fibrosis marker employ non-invasive diagnosis liver fibrosis evaluation severity liver fibrosis . They include laminin ( LN ) , hyaluronic acid ( HA ) , collagen type IV ( CIV ) , N-terminal propeptide collagen III ( PIIINP ) . However , study conduct explore role liver fibrosis marker evaluate prognosis liver cirrhosis . Our hypothesis LN , HA , CIV , PIIINP combination alone predict prognosis liver cirrhosis .</brief_summary>
	<brief_title>Effect 4 Liver Fibrosis Tests ( PIIINP , CIV , LN , HA ) Prognosis Liver Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>1 . Patients admit department . 2 . Patients diagnose liver cirrhosis . 3 . Patients sign informed consent agree test serum liver fibrosis marker ( PIIINP , CIV , LN , HA ) . 1 . Noncirrhotic patient . 2 . Malignancy . 3 . Severe cardiopulmonary disease . 4 . Severe infectious disease . 5 . Other disease shorten lifespan . 6 . Pregnant breastfeeding . 7 . Poor adherence .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Prognosis</keyword>
</DOC>